Yushan Liu Selected Research

Yushan Liu Research Topics

Disease

20	Neoplasms (Cancer) 03/2024 - 07/2008
10	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 08/2011
8	Breast Neoplasms (Breast Cancer) 03/2024 - 08/2009
3	Ischemia 05/2023 - 10/2009
3	Pain (Aches) 01/2023 - 11/2009
2	Hemorrhage 03/2024 - 05/2023
2	Aortic Coarctation 01/2024 - 01/2023
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2023 - 04/2016
2	Hypersensitivity (Allergy) 10/2021 - 06/2012
2	Inflammation (Inflammations) 10/2021 - 11/2009
2	Carcinogenesis 01/2016 - 08/2011
2	Hyperalgesia 06/2012 - 11/2009
2	Mesothelioma 07/2008 - 07/2008
2	Malignant Mesothelioma 07/2008 - 07/2008
1	Male Breast Neoplasms (Male Breast Cancer) 03/2024
1	Disease Resistance 01/2024
1	Ovarian Epithelial Carcinoma 12/2023
1	Ulcerative Colitis 11/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2023
1	Autoimmune Diseases (Autoimmune Disease) 11/2023
1	Stomach Neoplasms (Stomach Cancer) 10/2023
1	Carcinoma (Carcinomatosis) 10/2023
1	Ischemic Stroke 05/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2023
1	Cholestasis 05/2023
1	Liver Diseases (Liver Disease) 05/2023
1	Cerebral Hemorrhage 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Stroke (Strokes) 01/2023
1	Altitude Sickness (Mountain Sickness) 01/2022
1	Asthma (Bronchial Asthma) 10/2021
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 10/2021
1	Tertiary Lymphoid Structures 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Pathologic Complete Response 01/2021

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2016
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 08/2009
4	Small Interfering RNA (siRNA)IBA 10/2015 - 08/2011
4	Pemetrexed (MTA)FDA Link 05/2012 - 07/2008
3	Messenger RNA (mRNA)IBA 10/2023 - 11/2009
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 11/2019
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 07/2008
2	Coenzyme A (CoA)IBA 01/2024 - 01/2023
2	AntioxidantsIBA 11/2023 - 01/2017
2	Tight Junction ProteinsIBA 05/2023 - 01/2017
2	GoldIBA 01/2022 - 01/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 01/2020
2	AnthracyclinesIBA 01/2021 - 08/2009
2	AndrogensIBA 01/2020 - 09/2015
2	Sirtuin 1IBA 01/2020 - 01/2019
2	Heparin (Liquaemin)FDA LinkGeneric 01/2019 - 11/2009
2	Evans Blue (Blue, Evans)FDA Link 01/2017 - 04/2016
2	Cisplatin (Platino)FDA LinkGeneric 07/2008 - 07/2008
1	Schiff Bases (Schiff Base)IBA 03/2024
1	GelatinIBA 03/2024
1	HydrogelsIBA 03/2024
1	Long Noncoding RNAIBA 12/2023
1	NF-E2-Related Factor 2IBA 11/2023
1	AntibodiesIBA 11/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2023
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2023
1	Nicotine FDA Link 05/2023
1	Oxygen (Dioxygen)IBA 05/2023
1	OccludinIBA 05/2023
1	Glucose (Dextrose)FDA LinkGeneric 05/2023
1	Plasminogen Activators (Plasminogen Activator)IBA 05/2023
1	3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA 05/2023
1	Bile Acids and Salts (Bile Acids)IBA 05/2023
1	LipidsIBA 05/2023
1	Butyric Acid (Butanoic Acid)IBA 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	Pyruvate CarboxylaseIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Ion Channels (Ion Channel)IBA 01/2022
1	5-methylcytidineIBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2021
1	CaspasesIBA 10/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2021
1	ORALIT (ORS)IBA 01/2021
1	human ERBB2 proteinIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 12/2020
1	Peptides (Polypeptides)IBA 12/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2020
1	Therapeutic UsesIBA 01/2020

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 03/2024 - 07/2008
6	Therapeutics 01/2022 - 08/2009
3	Castration 01/2022 - 01/2020
2	Immunotherapy 10/2023 - 01/2021
1	Adjuvant Chemotherapy 03/2024
1	Neurological Rehabilitation 01/2023
1	Tai Ji (Tai Chi Chuan) 01/2023
1	Neoadjuvant Therapy 01/2021
1	Photochemotherapy (Photodynamic Therapy) 01/2020
1	Photothermal Therapy 01/2020